PALO ALTO, Calif., June 01, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (OTC: SRNEQ), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, is providing certain preliminary…Read More
Scilex Holding Company provides certain preliminary unaudited financial results for gross and net Sales for the one month ended May 2023 and yeartodate May 2023 based on currently available information
